Lara PN Jr, Mayerson E, Gertz E, Tangen C, et al. Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel. Eur Urol 2023 Apr 19:S0302-2838(23)02715-X. doi: 10.1016/j.eururo.2023.
PMID: 37085425